These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3143390)

  • 1. Local controlled release of 1-hydroxyethylidene diphosphonate using silicone-rubber matrices. Effects of sterilization on in vitro release and in vivo efficacy.
    Johnston TP; Bove EL; Bolling SF; Schoen FJ; Boyd JA; Golomb G; Levy RJ
    ASAIO Trans; 1988; 34(3):835-8. PubMed ID: 3143390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled-release drug delivery of diphosphonates to inhibit bioprosthetic heart valve calcification: release rate modulation with silicone matrices via drug solubility and membrane coating.
    Golomb G; Dixon M; Smith MS; Schoen FJ; Levy RJ
    J Pharm Sci; 1987 Apr; 76(4):271-6. PubMed ID: 3110404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of the calcification of glutaraldehyde pretreated bovine pericardium in a rat subdermal model by FeCl3 and ethanehydroxydiphosphonate: preincubation and polymeric controlled release studies.
    Hirsch D; Drader J; Pathak YV; Yee R; Schoen FJ; Levy RJ
    Biomaterials; 1993 Jul; 14(9):705-11. PubMed ID: 8399967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of calcification of bioprosthetic heart valve leaflets by Ca2+ diphosphonate pretreatment.
    Johnston TP; Schoen FJ; Levy RJ
    J Pharm Sci; 1988 Sep; 77(9):740-4. PubMed ID: 3147327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate.
    Levy RJ; Wolfrum J; Schoen FJ; Hawley MA; Lund SA; Langer R
    Science; 1985 Apr; 228(4696):190-2. PubMed ID: 3919445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the in vitro transport parameters for ethanehydroxy diphosphonate through a polyurethane membrane. A potential refillable reservoir drug delivery device.
    Johnston TP; Webb CL; Schoen FJ; Levy RJ
    ASAIO J; 1992; 38(3):M611-6. PubMed ID: 1457933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats.
    Levy RJ; Hawley MA; Schoen FJ; Lund SA; Liu PY
    Circulation; 1985 Feb; 71(2):349-56. PubMed ID: 3917378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy. Experimental studies of optimal dosages and therapeutic durations.
    Levy RJ; Schoen FJ; Lund SA; Smith MS
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):551-7. PubMed ID: 3116348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and controlled release studies.
    Hirsch D; Drader J; Thomas TJ; Schoen FJ; Levy JT; Levy RJ
    J Biomed Mater Res; 1993 Dec; 27(12):1477-84. PubMed ID: 8113234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of bioprosthetic heart valve calcification by sustained local delivery of Ca and Na diphosphonate via controlled release matrices.
    Golomb G; Dixon M; Smith MS; Schoen FJ; Levy RJ
    ASAIO Trans; 1986; 32(1):587-90. PubMed ID: 3778777
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of calcification of glutaraldehyde pretreated bovine pericardium through controlled release polymeric implants: studies of Fe3+, Al3+, protamine sulphate and levamisole.
    Pathak YV; Boyd J; Levy RJ; Schoen FJ
    Biomaterials; 1990 Nov; 11(9):718-23. PubMed ID: 2128616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local controlled-release of diphosphonates from ethylenevinylacetate matrices prevents bioprosthetic heart valve calcification.
    Levy RJ; Golomb G; Wolfrum J; Lund SA; Schoen FJ; Langer R
    Trans Am Soc Artif Intern Organs; 1985; 31():459-63. PubMed ID: 3939275
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of bioprosthetic heart valve tissue calcification by charge modification: effects of protamine binding by formaldehyde.
    Golomb G; Ezra V
    J Biomed Mater Res; 1991 Jan; 25(1):85-98. PubMed ID: 1902234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups.
    Webb CL; Benedict JJ; Schoen FJ; Linden JA; Levy RJ
    Ann Thorac Surg; 1988 Sep; 46(3):309-16. PubMed ID: 3137904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AL preincubation inhibits calcification of bioprosthetic heart valve tissue in the rat subdermal model.
    Webb CL; Schoen FJ; Levy RJ
    ASAIO Trans; 1988; 34(3):855-9. PubMed ID: 3143392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves.
    Chen W; Kim JD; Schoen FJ; Levy RJ
    J Biomed Mater Res; 1994 Dec; 28(12):1485-95. PubMed ID: 7876288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of anticalcification treatments on bioprosthetic heart valves implanted in sheep.
    Jones M; Eidbo EE; Hilbert SL; Ferrans VJ; Clark RE
    ASAIO Trans; 1988; 34(4):1027-30. PubMed ID: 3219249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of diphosphonates from synthetic polymers to inhibit calcification.
    Golomb G
    J Biomater Appl; 1987 Oct; 2(2):266-89. PubMed ID: 3144594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of Al3+ for prevention of bioprosthetic heart valve calcification.
    Webb CL; Flowers WE; Horton C; Schoen FJ; Levy RJ
    ASAIO Trans; 1990; 36(3):M408-10. PubMed ID: 2252713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol inhibition of porcine bioprosthetic heart valve cusp calcification is enhanced by reduction with sodium borohydride.
    Connolly JM; Alferiev I; Kronsteiner A; Lu Z; Levy RJ
    J Heart Valve Dis; 2004 May; 13(3):487-93. PubMed ID: 15222297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.